Close search modal
News

Mediwhale secures ₩20 billion in Series C funding, preparing for IPO

Korea Biomedical Review

Medical AI company Mediwhale said Tuesday it completed a 20 billion won ($13.1 million) Series C funding round.

Premier Partners led the investment, with KB Investment, Quad Investment Management, IMM Investment, Hana Ventures, AON Investment, and Startup Partners joining. Mediwhale’s total funding now stands at about 51.2 billion won.

Mediwhale wins EU CE MDR approval for retinal AI cardiovascular risk tool
How Mediwhale’s AI Sees Disease Before Doctors Can | Asia Tech Lens Podcast with Kevin Choi